The Resource for your Nonhuman Primate Research

We support innovation, reproducibility, and translation of preclinical research with high-quality biological development. We offer primate antibodies and recombinant proteins for pre-clinical NHP studies, NHP-specific reagents for in vitro assays, and have an industry wide antibody reactivity database for NHP species.

Our Products

Reactivity Database

Partner With Us

Recent Publications Using Our Reagents...

View All

NHPRR Product Catalog

 

Assay Reagent Catalog

 

New World Monkey Reagents

 

NHPRR Therapeutics Catalog

 

NHPRR News and Announcements

Follow the latest news on NHPRR's LinkedIn account and News Archives

 

NHP Reactivity

💬 Share your thoughts on a new chat-based tool for querying reagents  🚀 

What questions would you want answered?

2025 November 05

The TLR7 agonist vesatolimod does not measurably induce SIV expression in macaques receiving combination antiretroviral therapy initiated during chronic infection.

Swanstrom, Adrienne E Oswald, Kelli Fast, Randy Shoemaker, Rebecca Thomas, James A Pyle, Cathi Hull, Michael Bosche, William J Li, Yuan Breed, Matthew W Kramer, Joshua A Donohue, Duncan Trubey, Charles M Deleage, Claire Geleziunas, Romas Lifson, Jeffrey D Del Prete, Gregory Q

Antimicrob Agents Chemother

Anti-CD38 [OKT10]-PE

2025 November 01

Transient tissue residency and lymphatic egress define human CD56bright NK cell homeostasis.

Niehrs, Annika Hertwig, Laura Buggert, Marcus Nordström, Isabella Statzu, Maura Pampena, M Betina Samer, Sadia Knox, James J Strunz, Benedikt Sun, Dan Nguyen, Son Janoschka, Claudia Xing, Yafei Wu, Vincent H Sparrelid, Ernesto Alisjahbana, Arlisa Gao, Yu Sleiers, Natalie Strauss, Otto Filipovic, Iva Ponzetta, Andrea Medina-Andrade, Itzel Nilsén, Vera Jorns, Carl Cornillet, Martin Maucourant, Christopher Ziegenhain, Christoph Hengst, Julia Tweet, George Kroll, Kyle Golden, Gregory J Wedemeyer, Heiner Kürtüncü, Murat Dori, Yoav Itkin, Maxim G Klotz, Luisa Schaffer, Marie Ericzon, Bo-Göran Ivarsson, Martin A Paiardini, Mirko Nowak, Greg Willinger, Tim Reeves, R Keith Betts, Michael R Björkström, Niklas K

Nat Immunol

Anti-CD45 [ITS_rhCD45]-AF647

2025 October 29

CD4+ T Cells Are Key to Shaping a Protective Humoral Immunity in Primary Dengue 2 Virus Infection: Implications for Rational Vaccine Design.

Miranda-Santiago, Angel E Serrano-Collazo, Crisanta Cruz, Lorna A Henein, Sandra Alvarez, Laura Arana, Teresa Sánchez-Bibiloni, Jorge L Martinez, Melween I Roman, Chiara Burgos, Armando G Ramos-Benitez, Marcos J Caro-Rivera, Lourdes M Brien, James D Pinto, Amelia K de Silva, Aravinda M Sariol, Carlos A

Vaccines (Basel)

Anti-rhesus IgG1 [ena]-HRP Anti-rhesus IgG2 [dio]-HRP

2025 October 29

Identifying correlates of viral rebound timing and viral control in SHIV-infected infant macaques after ART interruption.

Obregon-Perko, Veronica Awasthi, Achal Barfield, Richard Berendam, Stella J Yagnik, Bhrugu Styles, Tiffany Tharp, Greg Gupta, Prachi M Mensah, Gloria Neja, Margaret Kumar, Mithra Fray, Emily Bu, Fan Pollara, Justin Tuyishime, Marina Ferrari, Guido Siliciano, Janet D Siliciano, Robert F Mavigner, Maud Silvestri, Guido Amara, Rama R Bosinger, Steve Fouda, Genevieve G Permar, Sallie R Chan, Cliburn Chahroudi, Ann

Sci Transl Med

Control antibody rhesus IgG1 (anti-DSP) [DSPR1]

News & Updates:

View All

2024 Aug 23

mAbsolve Parnership for Fc-silenced STR Antibodies

Today, we celebrate a milestone—partnering with mAbsolve to incorporate ‘STR’ mutations into our antibodies. This ensures targeted action without unintended immune responses, boosting rigor, effectiveness, and safety. By decreasing Fc-mediated interference (hello Fc-block!) and enhancing the signal-to-noise ratio, STR-enhanced antibodies will produce more robust and reproducible scientific findings. Expect many STR-enhanced antibodies soon!

READ MORE

2024 Apr 09

For your Acknowledgements section

Reagents used in these studies were provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116, U24 AI126683).

2024 Apr 11

NHPRR Linkedin

Follow our newest publications, products, and messages on LinkedIn!

READ MORE

2024 Apr 09

RRID Citation on Materials and Methods

For your Materials & Methods section: The rhesus recombinant Anti-CD8 beta [CD8b255R1] monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-2557, RRID:AB_2716321)

Contribute to the Resource

Help Us By:

Sharing Your Data: Our community-based reactivity database is built by users like you. Share your results!

Requesting a Reagent: We develop NHP-specific antibodies based on investigator-initiated requests, including: recombinant proteins for cell depletion, receptor activation, cytokine neutralization, co-stimulatory blockade, immunosuppression.

Licensing Our Reagents: Interested in using our antibodies on your assays? Reach us!

Sharing Your Publication: If you’ve recently published a study using an NHPRR reagent, add it to the publication database.

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2026